News AstraZeneca Introduces Trastuzumab Deruxtecan for HER2-Positive Breast Cancer in India "AstraZeneca's introduction of Trastuzumab Deruxtecan in India presents a significant milestone in treating HER2-positive breast cancer. Developed collaboratively with Daiichi Sankyo.
News Triple I Launches at UN Assembly The Impact Investment Initiative for Global Health (Triple I) made its debut at the United Nations General Assembly, with USAID-supported SAMRIDH Healthcare Blended Finance Facility and IPE Global among its 37 founding members.
